Michael Zinda Repare Therapeutics Inc. (RPTX) insider trading activity

RPTX Quotes by TradingView

Michael Zinda is EVP, CHIEF SCIENTIFIC OFFICER of Repare Therapeutics Inc.. Currently has a direct ownership of 71,908 shares of RPTX, which is worth approximately $269,655. The most recent transaction as insider was on Dec 21, 2020, when has been sold 40,000 shares (Common Stock) at a price of $2.42 per share, resulting in proceeds of $96,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.9K
0% 3M change
19.61% 12M change
Total Value Held $269,655

Michael Zinda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2020
BUY
Exercise of conversion of derivative security
$96,800 $2.42 p/Share
40,000 Added 24.21%
125,229 Common Stock
Dec 18 2020
SELL
Open market or private sale
$289,904 $34.84 p/Share
8,321 Reduced 8.89%
85,229 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$17,141 $2.06 p/Share
8,321 Added 8.17%
93,550 Common Stock
Dec 16 2020
SELL
Open market or private sale
$318,744 $35.59 p/Share
8,956 Reduced 9.51%
85,229 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$14,688 $1.64 p/Share
8,956 Added 8.68%
94,185 Common Stock
MZ

Michael Zinda

EVP, CHIEF SCIENTIFIC OFFICER
St Laurent, A8

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPTX